Short bowel condition Withdrawn Phase 2 Trials for Tocofersolan (DB11635)

Also known as: Short-bowel syndrome / Short Bowel Syndrome / Congenital volvulus

IndicationStatusPhase
DBCOND0020575 (Short bowel condition)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03582384Use of Tocofersolan (VedropĀ®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and ChildrenTreatment